NVAX Today - Jul 14: Stock Takes a Small Dive
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
NVAX Today - Jul 14: Stock Takes a Small Dive
-
ナレーター：
-
著者：
So, what happened? Well, NVAX started the day strong, but then it kinda fizzled out. It got smoked, closing lower than it opened. The volume was way off too—like, it barely hit a fraction of its usual trading. Not the best look.
Now, why did this happen? There’s a lot of chatter about Novavax hitting over a year high recently, and folks were wondering if the new flu-COVID shot from Sanofi could be a game changer. But the excitement didn’t last long. Even with some positive earnings news—like beating expectations on EPS—investors just weren’t feeling it today. A lot of people were probably just cashing in their chips, you know? When the hype wears off, sometimes it’s just sell, sell, sell.
Also, there’s some buzz in the market about other stocks that are really catching people’s eye. Gilead Sciences is one that’s been getting some love lately, which might’ve pulled attention away from Novavax. You know how it goes—everyone’s looking for the next big thing, and sometimes that means a stock like NVAX gets left in the dust.
One more thing worth mentioning is that Novavax’s Q1 earnings report showed some decent numbers, but they’re still dealing with some margin trends that aren’t looking too hot. So, yeah, that one stung a bit for investors hoping for a bounce-back.
To wrap it up, Novavax had a rough day, but it’s still in the game. Stocks go up and down, and today was just one of those down days for NVAX. Remember, I’m just here to share info, not give financial advice. Keep it chill, and happy investing!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません